COVID-19 in pregnancy

[1]  A. Papageorghiou,et al.  Maternal and Neonatal Morbidity and Mortality Among Pregnant Women With and Without COVID-19 Infection , 2021, JAMA pediatrics.

[2]  C. Olson,et al.  Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons , 2021, The New England journal of medicine.

[3]  K. Ault,et al.  ISIDOG Consensus Guidelines on COVID-19 Vaccination for Women before, during and after Pregnancy , 2021, Journal of clinical medicine.

[4]  L. Roncati,et al.  Nucleoside‐modified messenger RNA COVID‐19 vaccine platform , 2021, Journal of medical virology.

[5]  Gilbert GREUB,et al.  SARS-CoV-2 ACE-receptor detection in the placenta throughout pregnancy , 2020, Clinical Microbiology and Infection.

[6]  M. Guida,et al.  Risk factors associated with adverse fetal outcomes in pregnancies affected by Coronavirus disease 2019 (COVID-19): a secondary analysis of the WAPM study on COVID-19 , 2020, Journal of perinatal medicine.

[7]  G. Zanelli,et al.  High density of IgG4-secreting plasma cells in the fibrotic tissue from a surgically resected tracheal ring impaired by complex subglottic stenosis post-tracheostomy as immune expression of a Th2 response due to severe COVID-19 , 2020, Annals of Hematology.

[8]  S. Lye,et al.  Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia , 2020, American Journal of Obstetrics and Gynecology.

[9]  H. Taylor,et al.  Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis , 2020, American Journal of Obstetrics and Gynecology.

[10]  L. Roncati,et al.  The «moonlighting protein» able to explain the Th1 immune lockdown in severe COVID-19☆ , 2020, Medical Hypotheses.

[11]  Nehla Banu,et al.  Protective role of ACE2 and its downregulation in SARS-CoV-2 infection leading to Macrophage Activation Syndrome: Therapeutic implications , 2020, Life Sciences.

[12]  W. Barth,et al.  Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity. , 2020, Obstetrics and gynecology.

[13]  A. Benachi,et al.  Transplacental transmission of SARS-CoV-2 infection , 2020, Nature Communications.

[14]  L. Roncati,et al.  Signals of Th2 immune response from COVID-19 patients requiring intensive care , 2020, Annals of Hematology.

[15]  L. Roncati,et al.  What about the original antigenic sin of the humans versus SARS-CoV-2? , 2020, Medical Hypotheses.

[16]  A. Manenti,et al.  Renin-angiotensin system: The unexpected flaw inside the human immune system revealed by SARS-CoV-2 , 2020, Medical Hypotheses.

[17]  G. Barbolini,et al.  New advances on placental hydrops and related villous lymphatics. , 2015, Lymphology.

[18]  D. MacIntyre,et al.  The Th1:Th2 Dichotomy of Pregnancy and Preterm Labour , 2012, Mediators of inflammation.

[19]  N. Hooper,et al.  Tumor Necrosis Factor-α Convertase (ADAM17) Mediates Regulated Ectodomain Shedding of the Severe-acute Respiratory Syndrome-Coronavirus (SARS-CoV) Receptor, Angiotensin-converting Enzyme-2 (ACE2) , 2005, Journal of Biological Chemistry.

[20]  H. Schlebusch,et al.  Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. , 1998, Biochemical and biophysical research communications.